Clinical Trial: MEthylphenidate in ADHD - Addiction(s) Comorbidity: Value of Adding a Cognitive Remediation Program to Improve Short- and Medium-term Therapeutic Response

U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT06906328) titled 'MEthylphenidate in ADHD - Addiction(s) Comorbidity: Value of Adding a Cognitive Remediation Program to Improve Short- and Medium-term Therapeutic Response' on Jan. 23.

Brief Summary: MEthylphenidate in ADHD - Addiction(s) comorbidity: benefit of adding a cognitive remediation program to improve short- and medium-term therapeutic response

Study Start Date: June 15

Study Type: INTERVENTIONAL

Condition: ADHD-add

Intervention: BEHAVIORAL: Cognitive remediation program, with the PRESCO(R) software

The program runs for 12 weeks, with two sessions per week, one with a neuropsychologist. In the first 4 weeks, the patient will have we...